Annual CFF
$37.53 M
+$37.67 M+26910.00%
December 31, 2023
Summary
- As of February 7, 2025, NSPR annual cash flow from financing activities is $37.53 million, with the most recent change of +$37.67 million (+26910.00%) on December 31, 2023.
- During the last 3 years, NSPR annual CFF has risen by +$21.14 million (+128.94%).
- NSPR annual CFF is now at all-time high.
Performance
NSPR Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFF
-$965.00 K
-$18.82 M-105.40%
September 30, 2024
Summary
- As of February 7, 2025, NSPR quarterly cash flow from financing activities is -$965.00 thousand, with the most recent change of -$18.82 million (-105.40%) on September 30, 2024.
- Over the past year, NSPR quarterly CFF has dropped by -$965.00 thousand (-100.00%).
- NSPR quarterly CFF is now -102.57% below its all-time high of $37.53 million, reached on June 30, 2023.
Performance
NSPR Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFF
$16.89 M
-$965.00 K-5.40%
September 30, 2024
Summary
- As of February 7, 2025, NSPR TTM cash flow from financing activities is $16.89 million, with the most recent change of -$965.00 thousand (-5.40%) on September 30, 2024.
- Over the past year, NSPR TTM CFF has dropped by -$20.64 million (-55.00%).
- NSPR TTM CFF is now -67.18% below its all-time high of $51.46 million, reached on March 31, 2021.
Performance
NSPR TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
NSPR Cash From Financing Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +10000.0% | -100.0% | -55.0% |
3 y3 years | +128.9% | -2657.1% | -56.8% |
5 y5 years | +180.7% | -107.9% | +2.2% |
NSPR Cash From Financing Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | at high | >+9999.0% | -102.6% | at low | -55.0% | >+9999.0% |
5 y | 5-year | at high | >+9999.0% | -102.6% | at low | -67.2% | >+9999.0% |
alltime | all time | at high | >+9999.0% | -102.6% | +8.4% | -67.2% | +795.9% |
InspireMD Cash From Financing History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2024 | - | -$965.00 K(-105.4%) | $16.89 M(-5.4%) |
Jun 2024 | - | $17.85 M(>+9900.0%) | $17.85 M(-52.4%) |
Mar 2024 | - | $0.00(0.0%) | $37.53 M(0.0%) |
Dec 2023 | $37.53 M(<-9900.0%) | $0.00(0.0%) | $37.53 M(0.0%) |
Sep 2023 | - | $0.00(-100.0%) | $37.53 M(+0.3%) |
Jun 2023 | - | $37.53 M(>+9900.0%) | $37.43 M(<-9900.0%) |
Mar 2023 | - | $0.00(0.0%) | -$140.00 K(0.0%) |
Dec 2022 | -$140.00 K(-100.4%) | $0.00(-100.0%) | -$140.00 K(0.0%) |
Sep 2022 | - | -$103.00 K(+178.4%) | -$140.00 K(+94.4%) |
Jun 2022 | - | -$37.00 K(<-9900.0%) | -$72.00 K(+111.8%) |
Mar 2022 | - | $0.00(0.0%) | -$34.00 K(-100.1%) |
Dec 2021 | $35.03 M(+113.7%) | $0.00(-100.0%) | $35.03 M(-10.4%) |
Sep 2021 | - | -$35.00 K(-3600.0%) | $39.10 M(-0.3%) |
Jun 2021 | - | $1000.00(-100.0%) | $39.23 M(-23.8%) |
Mar 2021 | - | $35.07 M(+762.0%) | $51.46 M(+213.9%) |
Dec 2020 | $16.39 M(+158.8%) | $4.07 M(+4420.0%) | $16.39 M(+33.0%) |
Sep 2020 | - | $90.00 K(-99.3%) | $12.33 M(-25.4%) |
Jun 2020 | - | $12.23 M(>+9900.0%) | $16.53 M(+161.4%) |
Mar 2020 | - | $3000.00(-25.0%) | $6.32 M(-0.2%) |
Dec 2019 | $6.33 M(-52.6%) | $4000.00(-99.9%) | $6.33 M(-0.2%) |
Sep 2019 | - | $4.29 M(+111.1%) | $6.35 M(-26.5%) |
Jun 2019 | - | $2.03 M(>+9900.0%) | $8.64 M(-19.0%) |
Mar 2019 | - | $16.00 K(-15.8%) | $10.67 M(-20.2%) |
Dec 2018 | $13.37 M(+188.6%) | $19.00 K(-99.7%) | $13.37 M(-5.2%) |
Sep 2018 | - | $6.57 M(+61.8%) | $14.10 M(+87.5%) |
Jun 2018 | - | $4.06 M(+49.4%) | $7.52 M(+123.3%) |
Mar 2018 | - | $2.72 M(+262.4%) | $3.37 M(-27.3%) |
Dec 2017 | $4.63 M | $750.00 K(-7600.0%) | $4.63 M(+63.7%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2017 | - | -$10.00 K(-88.9%) | $2.83 M(-81.6%) |
Jun 2017 | - | -$90.00 K(-102.3%) | $15.42 M(+1.6%) |
Mar 2017 | - | $3.98 M(-478.3%) | $15.17 M(+29.6%) |
Dec 2016 | $11.70 M(+35.8%) | -$1.05 M(-108.4%) | $11.70 M(-0.6%) |
Sep 2016 | - | $12.58 M(-3842.9%) | $11.77 M(-773.2%) |
Jun 2016 | - | -$336.00 K(-165.1%) | -$1.75 M(-28.0%) |
Mar 2016 | - | $516.00 K(-152.2%) | -$2.43 M(-128.2%) |
Dec 2015 | $8.62 M(+4.2%) | -$988.00 K(+5.1%) | $8.62 M(-46.3%) |
Sep 2015 | - | -$940.00 K(-7.4%) | $16.05 M(-15.2%) |
Jun 2015 | - | -$1.01 M(-108.8%) | $18.93 M(-4.9%) |
Mar 2015 | - | $11.56 M(+79.3%) | $19.91 M(+140.7%) |
Dec 2014 | $8.27 M(-15.3%) | $6.45 M(+232.5%) | $8.27 M(+353.5%) |
Sep 2014 | - | $1.94 M(-5202.6%) | $1.82 M(-1686.1%) |
Jun 2014 | - | -$38.00 K(-50.6%) | -$115.00 K(-100.8%) |
Mar 2014 | - | -$77.00 K(-100.5%) | $14.02 M(-7.3%) |
Dec 2013 | $9.76 M(-35.4%) | - | - |
Jun 2013 | - | $14.09 M(<-9900.0%) | $15.12 M(+1369.7%) |
Jun 2013 | $15.12 M(+55.1%) | - | - |
Mar 2013 | - | -$20.00 K(-103.2%) | $1.03 M(+7.7%) |
Dec 2012 | - | $617.00 K(+42.8%) | $955.00 K(+291.4%) |
Sep 2012 | - | $432.00 K(-559.6%) | $244.00 K(-78.2%) |
Jun 2012 | $9.75 M(-8.6%) | - | - |
Mar 2012 | - | -$94.00 K(0.0%) | $1.12 M(-89.5%) |
Dec 2011 | $10.67 M(>+9900.0%) | -$94.00 K(-106.7%) | $10.67 M(-0.9%) |
Sep 2011 | - | $1.41 M(-1535.7%) | $10.76 M(+15.0%) |
Jun 2011 | - | -$98.00 K(-101.0%) | $9.36 M(-1.0%) |
Mar 2011 | - | $9.45 M | $9.45 M |
Jun 2010 | $20.00 K(>+9900.0%) | - | - |
Jun 2009 | $0.00 | - | - |
FAQ
- What is InspireMD annual cash flow from financing activities?
- What is the all time high annual CFF for InspireMD?
- What is InspireMD annual CFF year-on-year change?
- What is InspireMD quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for InspireMD?
- What is InspireMD quarterly CFF year-on-year change?
- What is InspireMD TTM cash flow from financing activities?
- What is the all time high TTM CFF for InspireMD?
- What is InspireMD TTM CFF year-on-year change?
What is InspireMD annual cash flow from financing activities?
The current annual CFF of NSPR is $37.53 M
What is the all time high annual CFF for InspireMD?
InspireMD all-time high annual cash flow from financing activities is $37.53 M
What is InspireMD annual CFF year-on-year change?
Over the past year, NSPR annual cash flow from financing activities has changed by +$37.67 M (+26910.00%)
What is InspireMD quarterly cash flow from financing activities?
The current quarterly CFF of NSPR is -$965.00 K
What is the all time high quarterly CFF for InspireMD?
InspireMD all-time high quarterly cash flow from financing activities is $37.53 M
What is InspireMD quarterly CFF year-on-year change?
Over the past year, NSPR quarterly cash flow from financing activities has changed by -$965.00 K (-100.00%)
What is InspireMD TTM cash flow from financing activities?
The current TTM CFF of NSPR is $16.89 M
What is the all time high TTM CFF for InspireMD?
InspireMD all-time high TTM cash flow from financing activities is $51.46 M
What is InspireMD TTM CFF year-on-year change?
Over the past year, NSPR TTM cash flow from financing activities has changed by -$20.64 M (-55.00%)